16 min listen
The Science of Janus Kinase Inhibitors Across Immunologic Diseases
The Science of Janus Kinase Inhibitors Across Immunologic Diseases
ratings:
Length:
35 minutes
Released:
Feb 29, 2024
Format:
Podcast episode
Description
Do you know how to integrate the current evidence about Janus kinase (JAK) inhibitors? Credit available for this activity expires: 2/28/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000237?ecd=bdc_podcast_libsyn_mscpedu
Released:
Feb 29, 2024
Format:
Podcast episode
Titles in the series (100)
Appropriate Treatment of Atrial Fibrillation: Which Dose for Which Patient?: Drs Ruff and Bode review the complexities of NOAC dosage in various patient groups. --- Full URLs: Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/923821 ?src=mkm_podcast_addon_923821 by Keeping Current CME